Mirati Therapeutics, Inc. (NASDAQ:MRTX – Free Report) – Research analysts at B. Riley lifted their FY2024 earnings estimates for Mirati Therapeutics in a report released on Monday, July 24th. B. Riley analyst K. Patel now forecasts that the biotechnology company will post earnings per share of ($9.27) for the year, up from their previous estimate […]
This man bought 2 Flair tickets to Florida but the flight didn t exist cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
Mirati Therapeutics (NASDAQ:MRTX – Free Report) had its price objective cut by B. Riley from $51.00 to $45.00 in a research note released on Monday, Marketbeat.com reports. They currently have a neutral rating on the biotechnology company’s stock. B. Riley also issued estimates for Mirati Therapeutics’ FY2024 earnings at ($9.27) EPS and FY2025 earnings at […]
Morgan Stanley Trims Mirati Therapeutics (NASDAQ:MRTX) Target Price to $42 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report)’s share price dropped 3.6% during trading on Tuesday . The stock traded as low as $37.53 and last traded at $37.70. Approximately 245,054 shares changed hands during trading, a decline of 77% from the average daily volume of 1,088,993 shares. The stock had previously closed at $39.11. […]